Nicholas T. Woods, Ph.D.
Affiliations: | 2008 | University of South Florida, Tampa, FL, United States |
Area:
Molecular BiologyGoogle:
"Nicholas Woods"Parents
Sign in to add mentor| Alvaro Monteiro | grad student | University of South Florida | ||
| Hong-Gang Wang | grad student | 2008 | University of South Florida | |
| (Regulation of Bax activation and apoptosis by Src and acetylated mutant p53.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kour S, Rana S, Kubica SP, et al. (2022) Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells. The Journal of Biological Chemistry. 101890 |
| Mendoza-Fandiño G, Lyra PCM, Nepomuceno TC, et al. (2021) Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics : Ejhg |
| Krieger KL, Hu WF, Ripperger T, et al. (2019) Functional Impacts of the BRCA1-mTORC2 Interaction in Breast Cancer. International Journal of Molecular Sciences. 20 |
| Hu WF, Krieger KL, Lagundžin D, et al. (2019) CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discovery. 5: 105 |
| Krieger KL, Hu W, Ripperger T, et al. (2019) Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer Cancer Research |
| Buckley MA, Woods NT, Tyrer JP, et al. (2018) Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research |
| Harro CM, Mendoza-Fandino G, Woods NT, et al. (2017) Abstract 1306: Two distinct regulatory mechanisms underlie estrogen receptor negative breast cancer susceptibility at the 2p23.2 locus Epidemiology. 77: 1306-1306 |
| Woods NT, Baskin R, Golubeva V, et al. (2016) Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine. 1 |
| Vaclová T, Woods NT, Megías D, et al. (2016) Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor Olaparib by a dominant negative effect. Human Molecular Genetics |
| Jhuraney A, Woods NT, Wright G, et al. (2016) PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer. Molecular Cancer Therapeutics |